Dictionary

allow_url_fopen is ENABLED Dictionary Search

haemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
Epigenetic Silencing Challenges AAV Gene Therapy Durability - European Medical Journal
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
Hope for haemophilia patients - Trinidad Express Newspapers
Raising the bar in haemophilia A care - Roche
Number of people with bleeding disorders worldwide in 2024, by condition - Statista
Journeying Towards Excellence in the Care of Patients with Haemophilia | JBM - Dove Medical Press
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Therapeutic advances in hemophilia: from molecular innovation to patient-centered global care - Frontiers
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
JEADV Clinical Practice | Clinical Dermatology and Venereology Journal - Wiley Online Library
Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran - AJMC
Pfizer says patient dies after receiving hemophilia drug in trial - Reuters
Sobi to Showcase Scientific advances and Commitment to the Haemophilia community at EAHAD 2026 - Yahoo Finance
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Transformative approaches in hemophilia management: from traditional therapies to prenatal stem cell treatment - Frontiers
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
Boy survives rare blood disorder after critical care at hospital - The Times of India
Enhancing Engagement to Support Shared Decision Making Within Haemophilia: Development of Materials for People With Haemophilia, Caregivers and Healthcare Professionals - Wiley Online Library
Assessing stigma in a predominantly male hemophilia population: a Chinese cross-sectional study - Frontiers
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Development of a short form of the Swedish version of the Hemophilia Activities List - Nature
Hull teenager first to be treated with new haemophilia drug - BBC
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B | New England Journal of Medicine - The New England Journal of Medicine
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
Early diagnosis reduces treatment burden in hemophilia A children - Hemophilia News Today
European Medicines Agency Issues Positive Opinion for Concizumab Label Update in Hemophilia - Docwire News
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report - Frontiers
NICE Recommends First Subcutaneous Option for Haemophilia B - Medscape
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Breaking sex biases: access for all in haemophilia care - The Lancet
Haemophilia gene therapy patients thriving over a decade after treatment - University College London
FDA expands approvals for Novartis lipid drug, Novo haemophilia prophylatic - FirstWord Pharma
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Six biotech companies leading the charge in hemophilia treatment - Labiotech.eu
Pfizer sets up Hympavzi expansion into haemophilia A or B with inhibitors - FirstWord Pharma
Invited Medical Presentation Abstracts - 2025 - Haemophilia - Wiley Online Library
NHS broadens access to haemophilia A drug Hemlibra - pharmaphorum
Advances in hemophilia treatment | Windyga | Acta Haematologica Polonica - Via Medica Journals
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - AJMC
Pfizer reports positive results from Phase III BASIS trial for haemophilia - Clinical Trials Arena
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
Roche's Hemlibra follow-up set for phase 3 in haemophilia A - pharmaphorum
Karnataka launches ‘Kusuma Sanjeevini’ to provide free preventive treatment for haemophilia patients at 3 - The Times of India
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
Pfizer confirms patient death in Hympavzi hemophilia extension study - Fierce Pharma
Re-evaluating European Haemophilia Standards: Towards a More Inclusive Global Framework - European Medical Journal
Discovery could improve treatment for people with hemophilia A - Medical Xpress
Efficacy of extended half-life factor VIII concentrate (Elocta) compared to standard half-life factor VIII products in patients with severe hemophilia A — impact on treatment adherence and patient preferences | Zdziarska | Acta Haematologica Polonica - Via Medica Journals
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patients - Pharmaceutical Technology
Preventing bleeds before they happen: understanding prophylaxis in haemophilia care - The Hindu
Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B - PMLiVE
FDA Approves Jivi for Pediatric Patients Aged 7 to 12 Years With Hemophilia A - AJMC
Entering a New Era in Protection in Haemophilia A - European Medical Journal
Multifactorial assessment of cardiovascular risk in patients with severe hemophilia from the lower Silesia region in Poland | Podolak-Dawidziak | Acta Haematologica Polonica - Via Medica Journals
100 Years of von Willebrand Disease - European Medical Journal
Novo Nordisk presents promising findings for haemophilia treatment - Pharmafile
Acquired hemophilia A in a patient with small lymphocytic lymphoma and SARS-CoV-2 infection - Via Medica Journals
Prevalence and Clinical Correlation of Intron 22 Inversion in Hemophilia A in Northeast India - Cureus
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A | Genes & Immunity - Nature
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Gene therapy frees hemophilia patient from constant worry, needles - Harvard Gazette
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
K'taka launches ‘Kusuma Sanjeevini’ scheme to provide free preventive care for haemophilia patients | Bengaluru - Hindustan Times
Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients - Nature
Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film - Fierce Pharma
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
ICMR's NIIH develops simple point of care test for haemophilia A, Von Willebrand Disease - The Economic Times
FDA clears Sanofi's siRNA as first rebalancing agent for all haemophilia patients - FirstWord Pharma
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A | New England Journal of Medicine - The New England Journal of Medicine
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A - The New England Journal of Medicine
Haemophilia - The Lancet
Haemophilia patients face shortage of clotting injections at MKCG - The Times of India
Articles about Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B - PMLiVE
Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment - ThePrint
Haemophilia A in infants - Roche
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study - The Lancet
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study - The Lancet
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation - Nature
Recommendations of Expert Group of Polish Society of Pediatric Oncology and Hematology on use of immune tolerance induction (ITI) in pediatric patients with hemophilia A complicated by a factor VIII inhibitor | Wojdalska | Acta Haematologica Polonica - Via Medica Journals
Rare within rare: Women with haemophilia - Roche
From patient to healer: Haemophilia warrior Dr Suresh Hanagavadi wins Padma Shri - The Times of India
Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review - Wiley Online Library
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A - The New England Journal of Medicine
Novo Nordisk’s haemophilia A drug stops bleeds in 74% of children - Clinical Trials Arena
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List - The Lancet
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophi;ia a,   hsemophilia a,   jaemophilia a,   haempphilia a,   harmophilia a,   haemiphilia a,   haemophiliaa ,   haemohpilia a,   haemoohilia a,   haempohilia a,   haeemophilia a,   haemophilis a,   haemophilia a,   haemohilia a,   aemophilia a,   haemo[hilia a,   haemophliia a,   haemophilia ,   haemphilia a,   haemophiila a,   hhaemophilia a,   haemophilia aa,   haemopgilia a,   haemophilai a,   haemophillia a,   haemophhilia a,   hae,ophilia a,   hamophilia a,   haemopilia a,   haenophilia a,   heamophilia a,   haemophiliaa,   haemophulia a,   haemopholia a,   hemophilia a,   ahemophilia a,   haemophilua a,   haemophiliia a,   haeophilia a,   haemophila a,   haemopjilia a,   haaemophilia a,   haemophiia a,   haeomphilia a,   haemophili a,   haemophlia a,   haemophiloa a,   haemophikia a,   gaemophilia a,   hawmophilia a,   haemopihlia a,   haemoophilia a,   hameophilia a,   haemophili aa,   haemmophilia a,   haemophiliaa a,   haemophilia s,   haemophiilia a,   haemopphilia a
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z